Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

Clinical trial NCT00355082 · COMPLETED

Trial details

NCT number: NCT00355082
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epilepsy, Partial

Start date: 2006-05-01
Primary completion: 2008-11-01
Enrollment: 226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.